D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.25 MYR -0.79% Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Cash Interest Paid
myr26.8m
CAGR 3-Years
61%
CAGR 5-Years
22%
CAGR 10-Years
52%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Cash Interest Paid
myr795k
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
11%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Cash Interest Paid
myr911.4k
CAGR 3-Years
17%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Cash Interest Paid
myr1.4m
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Cash Interest Paid
myr2.7m
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
6%
K
Kotra Industries Bhd
KLSE:KOTRA
Cash Interest Paid
myr27k
CAGR 3-Years
-67%
CAGR 5-Years
-58%
CAGR 10-Years
-43%
No Stocks Found

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.69 MYR
Undervaluation 26%
Intrinsic Value
Price
D

See Also

What is Duopharma Biotech Bhd's Cash Interest Paid?
Cash Interest Paid
26.8m MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Cash Interest Paid amounts to 26.8m MYR.

What is Duopharma Biotech Bhd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
52%

Over the last year, the Cash Interest Paid growth was 11%. The average annual Cash Interest Paid growth rates for Duopharma Biotech Bhd have been 61% over the past three years , 22% over the past five years , and 52% over the past ten years .

Back to Top